BRD9 is an essential regulator of glycolysis that creates an epigenetic vulnerability in colon adenocarcinoma.

Qunshan ZhuXiang GuWei WeiZheng WuFengqin GongXiaoqiang Dong

Published in: Cancer medicine (2022)

Together, our study revealed previously unidentified roles of BRD9 in colon cancer metabolism and tumor progression, indicating that BRD9 could be a valuable therapeutic target for COAD patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
squamous cell carcinoma
dna methylation
climate change
prognostic factors
peritoneal dialysis
poor prognosis
transcription factor